IP Library Granted Patent US 7,250,195
Granted Patent B1
US 7,250,195 · App. 11/623,411 · Granted Jul 31, 2007

Molecular plasma deposition of colloidal materials

Assignee: Ionic Fusion Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,250,195
App. No.
11/623,411
Granted
Jul 31, 2007
Kind
B1
Abstract

A molecular plasma discharge deposition method for depositing colloidal suspensions of biomaterials such as amino acids or other carbon based substances onto metal or nonmetal surfaces without loss of biological activity and/or structure is described. The method is based on generating a charged corona plasma which is then introduced into a vacuum chamber to deposit the biomaterial onto a biased substrate. The deposited biomaterials can be selected for a variety of medical uses, including coated implants for in situ release of pharmaceuticals.

Claims (26)

1. A molecular plasma method for deposition of a biomolecule onto a substrate, comprising,

generating an ionized molecular plasma corona under atmospheric conditions from a biomolecule in a liquid solution or suspension ejected from a conductive point connected to a voltage source sufficient to generate the ionized molecular plasma wherein the biomolecule in solution or suspension becomes charged, yet remains intact; and

directing the generated plasma through an orifice of an evacuated chamber housing a substrate at an induced potential opposite to the conductive point;

wherein the biomolecule is deposited onto the substrate without significantly altering the physical, functional or chemical characteristics.

2. The method of claim 1 wherein the suspension is colloidal.

3. The method of claim 1 wherein the liquid is water, alcohol or mixtures thereof.

4. The method of claim 1 wherein the generated corona discharge plasma comprises a positive or negatively charged plasma.

5. The method of claim 1 wherein the biomolecule is an amino acid, a nucleic acid base, or a polypeptide.

6. The method of claim 1 wherein the biomolecule is selected from the group consisting of carbon, copper oxide, an amino acid, an RNA or DNA base, catalase and mixtures thereof.

7. The method of claim 1 wherein the biomolecule is at least one of glycine, alanine, valine, leucine, arginine or mixtures thereof.

8. The method of claim 1 wherein the biomolecule is at least one of guanine, adenine, thymine, cytosine, uracil or mixtures thereof.

9. The method of claim 2 wherein the colloidal suspension is comprised of particles having a size range between about 100 angstroms and about 10,000 angstroms.

10. The method of claim 1 wherein the substrate is a metal, ceramic or a plastic.

11. A molecular plasma method for deposition of a biomolecule onto a substrate, comprising,

atomizing a solution or liquid suspension of a biomolecule into a partial vacuum from a conductive tip at a voltage sufficient to generate a plasma containing the intact charged biomolecule; and

directing the plasma through an orifice into an evacuated chamber housing a substrate connected to ground or held at a voltage opposite to the voltage of the conductive tip;

wherein the biomolecule deposits onto the substrate.

12. The method of claim 11 wherein the biomolecule is selected from the group consisting of carbon, copper oxide, an amino acid, an RNA or DNA base, catalase and mixtures thereof.

13. The method of claim 11 wherein the biomolecule is at least one of glycine, alanine, valine, leucine, arginine or mixtures thereof.

14. The method of claim 11 wherein the biomolecule is at least one of guanine, adenine, thymine, cytosine, uracil or mixtures thereof.

15. The method of claim 11 wherein the liquid suspension is a colloidal suspension comprised of particles having a size range between about 100 angstroms and about 10,000 angstroms.

16. The method of claim 11 wherein the solution or liquid suspension comprises water, alcohol, glycol or combinations thereof.

17. The method of claim 11 wherein the vacuum in the chamber is less than 100 mTorr.

18. The method of claim 11 wherein the voltage applied to the conductive tip is positive or negative in the range of 15,000 volts.

19. The method of claim 11 wherein the liquid is atomized into a vacuum in the range of 100 mTorr up to atmospheric pressure.

20. The method of claim 11 wherein the biomolecule is deposited on the substrate without significantly altering the physical, functional or chemical characteristics.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2018
From: METASCAPE, LLC
To: NORTHEASTERN UNIVERSITY
Reel/Frame 047458/0801 →
CHANGE OF NAME Recorded Feb 25, 2011
From: NANO SURFACE TECHNOLOGIES LLC
To: METASCAPE LLC
Reel/Frame 025874/0431 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2010
From: CHAMELEON SCIENTIFIC CORPORATION
To: NANOSURFACE TECHNOLOGIES LLC
Reel/Frame 024816/0401 →
SECURITY AGREEMENT Recorded May 7, 2010
From: CHAMELEON SCIENTIFIC CORPORATION
To: SUMMIT LIFE SCIENCE PARTNERS LLC
Reel/Frame 024351/0470 →
CHANGE OF NAME Recorded Jun 27, 2008
From: IONIC FUSION CORPORATION
To: CHAMELEON SCIENTIFIC CORPORATION
Reel/Frame 021158/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2007
From: STOREY, DANIEL M; MCGRATH, TERRENCE S; SHIMPI, TUSHAR M
To: IONIC FUSION CORPORATION
Reel/Frame 018818/0821 →
Continuity (1)
Provisional Application 6077710400 · Feb 27, 2006